These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38536646)

  • 41. The Value of Neutrophil-To-Lymphocyte Ratio for Evaluating Blood Stream Infection Caused by Carbapenem-Resistant
    Wu H; Mao Y; Du X; Zhao F; Jiang Y; Yu Y
    Front Med (Lausanne); 2022; 9():832655. PubMed ID: 35345766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
    Adrie C; Garrouste-Orgeas M; Ibn Essaied W; Schwebel C; Darmon M; Mourvillier B; Ruckly S; Dumenil AS; Kallel H; Argaud L; Marcotte G; Barbier F; Laurent V; Goldgran-Toledano D; Clec'h C; Azoulay E; Souweine B; Timsit JF;
    J Infect; 2017 Feb; 74(2):131-141. PubMed ID: 27838521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk Factors for Mortality Among Critical Acute Pancreatitis Patients with Carbapenem-Resistant Organism Infections and Drug Resistance of Causative Pathogens.
    Wu D; Huang Y; Xiao J; Qin G; Liu H; Peng J
    Infect Dis Ther; 2022 Jun; 11(3):1089-1101. PubMed ID: 35377132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical characteristics and prognosis of pneumonia-related bloodstream infections in the intensive care unit: a single-center retrospective study.
    Liu Y; Sun T; Cai Y; Zhai T; Huang L; Zhang Q; Wang C; Chen H; Huang X; Li M; Xia J; Gu S; Guo L; Yang B; Wu X; Lu B; Zhan Q
    Front Public Health; 2023; 11():1249695. PubMed ID: 37744495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study.
    Loiodice A; Bailly S; Ruckly S; Buetti N; Barbier F; Staiquly Q; Tabah A; Timsit JF;
    Clin Microbiol Infect; 2024 Sep; ():. PubMed ID: 39326671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study.
    Chen Y; Chen Y; Liu P; Guo P; Wu Z; Peng Y; Deng J; Kong Y; Cui Y; Liao K; Huang B
    BMC Geriatr; 2022 Jul; 22(1):573. PubMed ID: 35831805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria.
    Wang J; Mu M; Zhu J; Yang J; Tao Y; Chen Y; Hu Q; Zhou H; Zhao A; Niu T
    Ann Hematol; 2024 Oct; 103(10):4021-4031. PubMed ID: 38958702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors and predictors of carbapenem-resistant
    Papadimitriou-Olivgeris M; Fligou F; Spiliopoulou A; Koutsileou K; Kolonitsiou F; Spyropoulou A; Zotou A; Marangos M; Anastassiou ED; Christofidou M; Spiliopoulou I
    J Med Microbiol; 2017 Aug; 66(8):1092-1101. PubMed ID: 28758623
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant
    Zheng X; Wang JF; Xu WL; Xu J; Hu J
    Antimicrob Resist Infect Control; 2017; 6():102. PubMed ID: 29026535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.
    Goodman KE; Simner PJ; Klein EY; Kazmi AQ; Gadala A; Toerper MF; Levin S; Tamma PD; Rock C; Cosgrove SE; Maragakis LL; Milstone AM;
    Infect Control Hosp Epidemiol; 2019 May; 40(5):541-550. PubMed ID: 30915928
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Herrera S; Morata L; Sempere A; Verdejo M; Del Rio A; Martínez JA; Cuervo G; Hernández-Meneses M; Chumbita M; Pitart C; Puerta P; Monzó P; Lopera C; Aiello F; Mendoza S; Garcia-Vidal C; Soriano A; Bodro M
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant
    Zhen S; Zhao Y; Chen Z; Zhang T; Wang J; Jiang E; Zhang F; Mi Y; Zhu X; Han M; Xiao Z; Wang J; Feng S
    Front Cell Infect Microbiol; 2023; 13():1156651. PubMed ID: 37415825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant
    Zhu Y; Xiao T; Wang Y; Yang K; Zhou Y; Luo Q; Shen P; Xiao Y
    Infect Drug Resist; 2021; 14():5385-5393. PubMed ID: 34938086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study.
    Moehring RW; Sloane R; Chen LF; Smathers EC; Schmader KE; Fowler VG; Weber DJ; Sexton DJ; Anderson DJ
    PLoS One; 2013; 8(10):e76225. PubMed ID: 24098449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Impact of Nosocomial Bloodstream Infections on Mortality: A Retrospective Propensity-Matched Cohort Study.
    Petersiel N; Sherman A; Paul M
    Open Forum Infect Dis; 2021 Dec; 8(12):ofab552. PubMed ID: 34888398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Prognostic Factors of Bloodstream Infection in Immunosuppressed Elderly Patients: A Retrospective, Single-center, Five-year Cohort Study.
    Lin H; Gao Y; Qiu Y; Zhu H; Zhang S; Summah HD; Shi G; Cheng T; Yang Z; Feng Y
    Clin Interv Aging; 2022; 17():1647-1656. PubMed ID: 36425478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal.
    Garrouste-Orgeas M; Timsit JF; Tafflet M; Misset B; Zahar JR; Soufir L; Lazard T; Jamali S; Mourvillier B; Cohen Y; De Lassence A; Azoulay E; Cheval C; Descorps-Declere A; Adrie C; Costa de Beauregard MA; Carlet J;
    Clin Infect Dis; 2006 Apr; 42(8):1118-26. PubMed ID: 16575729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRO infection and the Use of MRSA-active Medication for Prophylaxis affect the Prognosis of Patients with Hematological Malignancies after CAR-T Infusion.
    Yang J; Hu H; Zhu X; Zou S; Song J; Liu D; He Y
    Int J Antimicrob Agents; 2023 Aug; 62(2):106874. PubMed ID: 37295537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.
    Giacobbe DR; Marelli C; Cattardico G; Fanelli C; Signori A; Di Meco G; Di Pilato V; Mikulska M; Mazzitelli M; Cattelan AM; Pallotto C; Francisci D; Calabresi A; Lombardi A; Gori A; Del Bono V; Aldieri C; Losito AR; Raffaelli F; Cortegiani A; Milazzo M; Del Puente F; Pontali E; De Rosa FG; Corcione S; Mularoni A; Russelli G; Giacomini M; Badalucco Ciotta F; Oltolini C; Serino FS; Momesso E; Spinicci M; Graziani L; Torti C; Trecarichi EM; Merli M; D'Amico F; Marchese A; Vena A; Bassetti M
    J Antimicrob Chemother; 2023 Oct; 78(10):2505-2514. PubMed ID: 37606528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria.
    Piantoni A; Houard M; Piga G; Zebian G; Ruffier des Aimes S; Holik B; Wallet F; Rouzé A; Kreitmann L; Loiez C; Labreuche J; Nseir S
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.